Back to Search
HAL MEADOWS, MD
MD
General Practice Physician
NPI: 1538233135Individual
Specialties, Licenses & Credentials
General Practice PhysicianPrimary
General Practice
Code: 208D00000X
G258440(CA)
Research & Publications (20)
The neuroprotective agent sipatrigine (BW619C89) potently inhibits the human tandem pore-domain K(+) channels TREK-1 and TRAAK.
PMID 11172753·Brain Res·2001
7-preclinical
Functional characterisation of human TASK-3, an acid-sensitive two-pore domain potassium channel.
PMID 11249964·Neuropharmacology·2001
7-preclinical
Cloning, localisation and functional expression of the human orthologue of the TREK-1 potassium channel.
PMID 10784345·Pflugers Arch·2000
7-preclinical
Population patch-clamp electrophysiology analysis of recombinant GABAA alpha1beta3gamma2 channels expressed in HEK-293 cells.
PMID 19556611·J Biomol Screen·2009
8-other
mGlu4 potentiation of K(2P)2.1 is dependant on C-terminal dephosphorylation.
PMID 17916432·Mol Cell Neurosci·2008
7-preclinical
EXTRA--a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer.
PMID 18472366·Int J Radiat Oncol Biol Phys·2008
3-trial
Novel 384-well population patch clamp electrophysiology assays for Ca2+-activated K+ channels.
PMID 17092914·J Biomol Screen·2007
7-preclinical
Improved functional expression of recombinant human ether-a-go-go (hERG) K+ channels by cultivation at reduced temperature.
PMID 18096051·BMC Biotechnol·2007
7-preclinical
Chemotherapy or no chemotherapy in clear margins after neoadjuvant chemoradiation in locally advanced rectal cancer: CHRONICLE. A randomised phase III trial of control vs. capecitabine plus oxaliplatin.
PMID 17434299·Clin Oncol (R Coll Radiol)·2007
8-other
A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study.
PMID 17262086·Br J Cancer·2007
3-trial
ACT II: the second UK phase III anal cancer trial.
PMID 16097568·Clin Oncol (R Coll Radiol)·2005
8-other
A phase I/II study of oxaliplatin when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group (CCOG) study.
PMID 16249791·Br J Cancer·2005
3-trial
Selective block of the human 2-P domain potassium channel, TASK-3, and the native leak potassium current, IKSO, by zinc.
PMID 15284350·J Physiol·2004
7-preclinical
Pathological staging of epidermoid anal carcinoma for the new era.
PMID 12780879·Colorectal Dis·2003
6-review
Acute hypoxia occludes hTREK-1 modulation: re-evaluation of the potential role of tandem P domain K+ channels in central neuroprotection.
PMID 12611912·J Physiol·2003
8-other
Distribution and expression of TREK-1, a two-pore-domain potassium channel, in the adult rat CNS.
PMID 11301200·Neuroscience·2001
7-preclinical
Recombinant hTASK1 is an O(2)-sensitive K(+) channel.
PMID 11478797·Biochem Biophys Res Commun·2001
8-other
Distribution analysis of human two pore domain potassium channels in tissues of the central nervous system and periphery.
PMID 11165377·Brain Res Mol Brain Res·2001
8-other
Mutation of histidine 286 of the human P2X4 purinoceptor removes extracellular pH sensitivity.
PMID 10718748·J Physiol·2000
7-preclinical
Cloning and functional expression of a human orthologue of rat vanilloid receptor-1.
PMID 11050376·Pain·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 705 WEST STREET
SUSANVILLE, CA 96130 - Phone
- (530) 257-7251
Quick Facts
- NPI
- 1538233135
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile